Prognostic impact of atrial fibrillation in acute coronary syndromes: Results from the ARIAM registry

European Heart Journal: Acute Cardiovascular Care

Volumn 3, Issue 2, 2014, Pages 141-148

  Almendro Delia, Manuel ^a   Valle Caballero, MaríA José ^a   Garcia Rubira, Juan C ^a   Muñoz Calero, Blanca ^a   Garcia Alcantara, Angel ^b   Reina Toral, Antonio ^c   Benítez Parejo, José ^d   Hidalgo Urbano, Rafael ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d Coresoft ^*  (Spain)

Author keywords

Acute coronary syndrome; atrial fibrillation; heart failure; myocardial infarction; propensity score; registry

Indexed keywords

ACUTE CORONARY SYNDROME; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; FEMALE; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; REGISTER; STATISTICS AND NUMERICAL DATA;

ACUTE CORONARY SYNDROME; ATRIAL FIBRILLATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; REGISTRIES; THROMBOLYTIC THERAPY;

EID: 84922249200     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613517370     Document Type: Article

References (42)

1. Goldberg RJ, Seeley D, Becker RC, et al. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J 1990; 119: 996–1001.
2. Sakata K, Kurihara H, Iwamori K, et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol 1997; 80: 1522–1527.
3. Torres M, Rocha S, Marques J, et al. Impact of atrial fibrillation in acute coronary syndromes. Rev Port Cardiol 2008; 27: 1407–1418.
4. Cui K, Gu S, Ding YS, et al. Effects of atrial fibrillation/atrial flutter on the short and medium-term prognosis of patients with acute myocardial infarction. J Interv Radiol 2008; 17: 594–596.
5. Galcera TJ, Melgarejo MA, Garcia AA, et al. Incidence, clinical characteristics and prognostic significance of supraventricular tachyarrhythmias in acute myocardial infarction [in Spanish]. Rev Esp Cardiol 1999; 52: 647–655.
6. Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J 2009; 30: 2019–2028.
7. Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience: Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30: 406–413.
8. Kinjo K, Sato H, Sato H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003; 92: 1150–1154.
9. Pizzetti F, Turazza FM, Franzosi MG, et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001; 86: 527–532.
10. Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000; 101: 969–974.
11. Schmitt J, Duray G, Gersch BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038–1045.
12. Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation 2011; 123: 1587–1593.
13. Angeli F, Reboldi G, Garofoli M, et al. A trial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep 2012; 14: 601–610.
14. Behar S, Zahavi Z, Goldbourt U, et al. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction: SPRINT Study Group. Eur Heart J 1992; 13: 45–50.
15. Eldar M, Canetti M, Rotstein Z, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era: SPRINT and Thrombolytic Survey Groups. Circulation 1998; 97: 965–970.
16. Lehto M, Snapinn S, Dickstein K, et al. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 2005; 26: 350–356.
17. Wong CK, White HD, Wilcox RG, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000; 140: 878–885.
18. Mehta RH, Dabbous OH, Granger CB, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol 2003; 92: 1031– 1036.
19. Berton G, Cordiano R, Cucchini F, et al. Atrial fibrillation during acute myocardial infarction: association with allcause mortality and sudden death after 7-year of follow-up. Int J Clin Pract 2009; 63: 712–721.
20. Asanin M, Perunicic J, Mrdovic I, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2005; 7: 671–676.
21. Pedersen OD, Bagger H, Kober L, et al. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction: TRACE Study Group: TRAndolapril Cardiac Evaluation. Eur Heart J 1999; 20: 748–754.
22. Saczynski JS, McManus D, Zhou Z, et al. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol 2009; 104: 169–174.
23. Trappolini M, Scorza A, Chillotti FM, et al. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients. Minerva Cardioangiol 2006; 54: 471–479.
24. Poçi D, Hartford M, Kalrsson T, et al. Effect of new versus known versus no atrial fibrillation on 30-day and 10-year mortality in patients with acute coronary syndrome. Am J Cardiol 2012; 110: 217–221.
25. Lau DH, Huynh LT, Chew DP, et al. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009; 104: 1317–1323.
26. Cha YM, Redfield MM, Shen WK, et al. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 2004; 109: 2839–2843.
27. Ehrlich JR, Nattel S and Hohnloser SH. A trial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002; 13: 399–405.
28. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107: 2920–2925.
29. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369–2429.
30. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569–2619.
31. Álvarez Bueno M, Vera Almazán A, Rodríguez García J. J., et al. Concept, development and objectives of project ARIAM [in Spanish]. Med Intensiva 1999; 23: 273–280.
32. Saturno PJ, Felices F, Segura J, et al. Reducing time delay in the thrombolysis of myocardial infarction: an internal quality improvement project. Am J Med Quality 2000; 15: 85–93.
33. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142–154.
34. Rubin DB. Estimating causal effects from large data sets using propensity scores, Ann Intern Med 1997; 127: 757–763.
35. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–2281.
36. Corradi D, Callegari S, Maestri R, et al. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med 2008; 5: 782–796.
37. Al Khdair D, Alshengeiti L, Elbarouni B, et al.; Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Coronary Events (CANRACE) Investigators. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Can J Cardiol 2012; 28: 443–449.
38. Lopes RD, Pieper KS, Horton JR, et al. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 2008; 94: 867–873.
39. Waldecker B. A trial fibrillation in myocardial infarction complicated by heart failure: cause or consequence?. Eur Heart J 1999; 20: 710–712.
40. Sankaranarayanan R, James MA, Nuta B, et al. Does atrial fibrillation beget ventricular fibrillation in patients with acute myocardial infarction? Pacing Clin Electrophysiol 2008; 31: 1612–1619.
41. Stenestrand U, Lindback J and Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA) Circulation 2005; 112: 3225–3231.
42. Danchin N, Fauchier L, Marijon E, et al. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart 2010; 96: 1809–1814.